<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-antioxidants-07-00095" class="ref">
 <label class="label">23.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Deep</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Singh</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Agarwal</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kroll</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Agarwal</surname>
    <given-names class="given-names">R.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Silymarin and silibinin cause G1 and G2â€“M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: A comparison of flavanone silibinin with flavanolignan mixture silymarin</article-title>
  <source class="source">Oncogene</source>
  <year class="year">2006</year>
  <volume class="volume">25</volume>
  <fpage class="fpage">1053</fpage>
  <lpage class="lpage">1069</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1038/sj.onc.1209146</pub-id>
  <?supplied-pmid 16205633?>
  <pub-id pub-id-type="pmid" class="pub-id">16205633</pub-id>
 </element-citation>
</ref>
